ID   TNNC1_HUMAN             Reviewed;         161 AA.
AC   P63316; O14800; P02590; P04463;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   22-JUL-2015, entry version 118.
DE   RecName: Full=Troponin C, slow skeletal and cardiac muscles;
DE            Short=TN-C;
GN   Name=TNNC1; Synonyms=TNNC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE, AND ACETYLATION AT MET-1.
RC   TISSUE=Heart muscle;
RX   PubMed=3951483; DOI=10.1002/mus.880090112;
RA   Roher A., Lieska N., Spitz W.;
RT   "The amino acid sequence of human cardiac troponin-C.";
RL   Muscle Nerve 9:73-77(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Slow skeletal muscle;
RX   PubMed=3166492; DOI=10.1016/0022-2836(88)90145-3;
RA   Gahlmann R., Wade R., Gunning R., Kedes L.;
RT   "Differential expression of slow and fast skeletal muscle troponin C.
RT   Slow skeletal muscle troponin C is expressed in human fibroblasts.";
RL   J. Mol. Biol. 201:379-391(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Slow skeletal muscle;
RX   PubMed=2250022;
RA   Schreier T., Kedes L., Gahlmann R.;
RT   "Cloning, structural analysis, and expression of the human slow twitch
RT   skeletal muscle/cardiac troponin C gene.";
RL   J. Biol. Chem. 265:21247-21253(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Margossian S.S., Yang F., Umeda P.K., Sciaky D., Anderson P.A.W.;
RT   "H. sapiens mRNA for cardiac ventricular troponin C in idiopathic
RT   dilated cardiomyopathy.";
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   STRUCTURE BY NMR OF 1-89.
RC   TISSUE=Heart muscle;
RX   PubMed=9315850; DOI=10.1021/bi971223d;
RA   Spyracopoulos L., Li M.X., Sia S.K., Gagne S.M., Chandra M.,
RA   Solaro R.J., Sykes B.D.;
RT   "Calcium-induced structural transition in the regulatory domain of
RT   human cardiac troponin C.";
RL   Biochemistry 36:12138-12146(1997).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS).
RX   PubMed=9219516; DOI=10.1111/j.1432-1033.1997.00611.x;
RA   Takeda S., Kobayashi T., Taniguchi H., Hayashi H., Maeda Y.;
RT   "Structural and functional domains of the troponin complex revealed by
RT   limited digestion.";
RL   Eur. J. Biochem. 246:611-617(1997).
RN   [8]
RP   STRUCTURE BY NMR OF 89-161.
RC   TISSUE=Heart muscle;
RX   PubMed=12732641; DOI=10.1074/jbc.M302497200;
RA   Lindhout D.A., Sykes B.D.;
RT   "Structure and dynamics of the C-domain of human cardiac troponin C in
RT   complex with the inhibitory region of human cardiac troponin I.";
RL   J. Biol. Chem. 278:27024-27034(2003).
RN   [9]
RP   VARIANT CMH13 GLN-29.
RX   PubMed=11385718; DOI=10.1002/humu.1143;
RA   Hoffmann B., Schmidt-Traub H., Perrot A., Osterziel K.J., Gessner R.;
RT   "First mutation in cardiac troponin C, L29Q, in a patient with
RT   hypertrophic cardiomyopathy.";
RL   Hum. Mutat. 17:524-524(2001).
RN   [10]
RP   VARIANT CMD1Z ARG-159.
RX   PubMed=15542288; DOI=10.1016/j.jacc.2004.08.027;
RA   Mogensen J., Murphy R.T., Shaw T., Bahl A., Redwood C., Watkins H.,
RA   Burke M., Elliott P.M., McKenna W.J.;
RT   "Severe disease expression of cardiac troponin C and T mutations in
RT   patients with idiopathic dilated cardiomyopathy.";
RL   J. Am. Coll. Cardiol. 44:2033-2040(2004).
RN   [11]
RP   CHARACTERIZATION OF VARIANT CMH13 GLN-29.
RX   PubMed=16302972; DOI=10.1111/j.1742-4658.2005.05001.x;
RA   Schmidtmann A., Lindow C., Villard S., Heuser A., Mugge A.,
RA   Gessner R., Granier C., Jaquet K.;
RT   "Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy,
RT   hinders the transduction of the protein kinase A dependent
RT   phosphorylation signal from cardiac troponin I to C.";
RL   FEBS J. 272:6087-6097(2005).
RN   [12]
RP   VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145, AND
RP   CHARACTERIZATION OF VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145.
RX   PubMed=18572189; DOI=10.1016/j.yjmcc.2008.05.003;
RA   Landstrom A.P., Parvatiyar M.S., Pinto J.R., Marquardt M.L., Bos J.M.,
RA   Tester D.J., Ommen S.R., Potter J.D., Ackerman M.J.;
RT   "Molecular and functional characterization of novel hypertrophic
RT   cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.";
RL   J. Mol. Cell. Cardiol. 45:281-288(2008).
RN   [13]
RP   CHARACTERIZATION OF VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145.
RX   PubMed=19439414; DOI=10.1074/jbc.M109.007021;
RA   Pinto J.R., Parvatiyar M.S., Jones M.A., Liang J., Ackerman M.J.,
RA   Potter J.D.;
RT   "A functional and structural study of troponin C mutations related to
RT   hypertrophic cardiomyopathy.";
RL   J. Biol. Chem. 284:19090-19100(2009).
CC   -!- FUNCTION: Troponin is the central regulatory protein of striated
CC       muscle contraction. Tn consists of three components: Tn-I which is
CC       the inhibitor of actomyosin ATPase, Tn-T which contains the
CC       binding site for tropomyosin and Tn-C. The binding of calcium to
CC       Tn-C abolishes the inhibitory action of Tn on actin filaments.
CC   -!- DISEASE: Cardiomyopathy, dilated 1Z (CMD1Z) [MIM:611879]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death.
CC       {ECO:0000269|PubMed:15542288}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic 13 (CMH13)
CC       [MIM:613243]: A hereditary heart disorder characterized by
CC       ventricular hypertrophy, which is usually asymmetric and often
CC       involves the interventricular septum. The symptoms include
CC       dyspnea, syncope, collapse, palpitations, and chest pain. They can
CC       be readily provoked by exercise. The disorder has inter- and
CC       intrafamilial variability ranging from benign to malignant forms
CC       with high risk of cardiac failure and sudden cardiac death.
CC       {ECO:0000269|PubMed:11385718, ECO:0000269|PubMed:18572189}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Cardiac muscle Tn-C can bind 3 calcium ions per
CC       molecule. Domain I does not bind calcium.
CC   -!- SIMILARITY: Belongs to the troponin C family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 4 EF-hand domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00448}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07897; CAA30736.1; -; mRNA.
DR   EMBL; M37984; AAA36772.1; -; Genomic_DNA.
DR   EMBL; AF020769; AAB91994.1; -; mRNA.
DR   EMBL; BC030244; AAH30244.1; -; mRNA.
DR   CCDS; CCDS2857.1; -.
DR   RefSeq; NP_003271.1; NM_003280.2.
DR   UniGene; Hs.118845; -.
DR   PDB; 1AP4; NMR; -; A=1-89.
DR   PDB; 1IH0; NMR; -; A=91-161.
DR   PDB; 1J1D; X-ray; 2.61 A; A/D=1-161.
DR   PDB; 1J1E; X-ray; 3.30 A; A/D=1-161.
DR   PDB; 1LXF; NMR; -; C=1-89.
DR   PDB; 1MXL; NMR; -; C=1-89.
DR   PDB; 1OZS; NMR; -; A=90-161.
DR   PDB; 1SPY; NMR; -; A=1-89.
DR   PDB; 1WRK; X-ray; 2.15 A; A/B=1-88.
DR   PDB; 1WRL; X-ray; 2.60 A; A/B/C/D/E/F=1-88.
DR   PDB; 2JT0; NMR; -; A=1-161.
DR   PDB; 2JT3; NMR; -; A=1-161.
DR   PDB; 2JT8; NMR; -; A=1-161.
DR   PDB; 2JTZ; NMR; -; A=1-161.
DR   PDB; 2JXL; NMR; -; A=1-89.
DR   PDB; 2KDH; NMR; -; A=91-161.
DR   PDB; 2KFX; NMR; -; T=1-89.
DR   PDB; 2KGB; NMR; -; C=1-89.
DR   PDB; 2KRD; NMR; -; C=1-89.
DR   PDB; 2L1R; NMR; -; A=1-89.
DR   PDB; 2L98; NMR; -; A=91-161.
DR   PDB; 2MKP; NMR; -; C=1-89.
DR   PDB; 2MLE; NMR; -; C=91-161.
DR   PDB; 2MLF; NMR; -; C=91-161.
DR   PDB; 2MZP; NMR; -; C=1-89.
DR   PDB; 3RV5; X-ray; 2.20 A; A/B/C/D=1-89.
DR   PDB; 3SD6; X-ray; 1.37 A; A=1-89.
DR   PDB; 3SWB; X-ray; 1.67 A; A=1-89.
DR   PDB; 4GJE; X-ray; 1.60 A; A=1-89.
DR   PDB; 4GJF; X-ray; 1.90 A; A=1-89.
DR   PDB; 4GJG; X-ray; 2.00 A; A=1-89.
DR   PDBsum; 1AP4; -.
DR   PDBsum; 1IH0; -.
DR   PDBsum; 1J1D; -.
DR   PDBsum; 1J1E; -.
DR   PDBsum; 1LXF; -.
DR   PDBsum; 1MXL; -.
DR   PDBsum; 1OZS; -.
DR   PDBsum; 1SPY; -.
DR   PDBsum; 1WRK; -.
DR   PDBsum; 1WRL; -.
DR   PDBsum; 2JT0; -.
DR   PDBsum; 2JT3; -.
DR   PDBsum; 2JT8; -.
DR   PDBsum; 2JTZ; -.
DR   PDBsum; 2JXL; -.
DR   PDBsum; 2KDH; -.
DR   PDBsum; 2KFX; -.
DR   PDBsum; 2KGB; -.
DR   PDBsum; 2KRD; -.
DR   PDBsum; 2L1R; -.
DR   PDBsum; 2L98; -.
DR   PDBsum; 2MKP; -.
DR   PDBsum; 2MLE; -.
DR   PDBsum; 2MLF; -.
DR   PDBsum; 2MZP; -.
DR   PDBsum; 3RV5; -.
DR   PDBsum; 3SD6; -.
DR   PDBsum; 3SWB; -.
DR   PDBsum; 4GJE; -.
DR   PDBsum; 4GJF; -.
DR   PDBsum; 4GJG; -.
DR   ProteinModelPortal; P63316; -.
DR   SMR; P63316; 1-161.
DR   BioGrid; 112988; 12.
DR   IntAct; P63316; 8.
DR   STRING; 9606.ENSP00000232975; -.
DR   ChEMBL; CHEMBL2095202; -.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB01375; Dihydroxyaluminium.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB00922; Levosimendan.
DR   DrugBank; DB00831; Trifluoperazine.
DR   PhosphoSite; P63316; -.
DR   BioMuta; TNNC1; -.
DR   DMDM; 54042075; -.
DR   MaxQB; P63316; -.
DR   PaxDb; P63316; -.
DR   PRIDE; P63316; -.
DR   DNASU; 7134; -.
DR   Ensembl; ENST00000232975; ENSP00000232975; ENSG00000114854.
DR   GeneID; 7134; -.
DR   KEGG; hsa:7134; -.
DR   UCSC; uc003deb.3; human.
DR   CTD; 7134; -.
DR   GeneCards; GC03M052485; -.
DR   GeneReviews; TNNC1; -.
DR   HGNC; HGNC:11943; TNNC1.
DR   HPA; CAB002450; -.
DR   HPA; HPA044848; -.
DR   HPA; HPA056897; -.
DR   MIM; 191040; gene.
DR   MIM; 611879; phenotype.
DR   MIM; 613243; phenotype.
DR   neXtProt; NX_P63316; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 155; Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA36632; -.
DR   eggNOG; COG5126; -.
DR   GeneTree; ENSGT00760000118901; -.
DR   HOGENOM; HOG000233018; -.
DR   HOVERGEN; HBG012180; -.
DR   InParanoid; P63316; -.
DR   KO; K05865; -.
DR   OMA; MNDIYKA; -.
DR   OrthoDB; EOG76X61W; -.
DR   PhylomeDB; P63316; -.
DR   TreeFam; TF318191; -.
DR   Reactome; REACT_16969; Striated Muscle Contraction.
DR   ChiTaRS; TNNC1; human.
DR   EvolutionaryTrace; P63316; -.
DR   GeneWiki; Troponin_C_type_1; -.
DR   GenomeRNAi; 7134; -.
DR   NextBio; 27913; -.
DR   PRO; PR:P63316; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; P63316; -.
DR   CleanEx; HS_TNNC1; -.
DR   ExpressionAtlas; P63316; baseline and differential.
DR   Genevisible; P63316; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005861; C:troponin complex; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; ISS:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0031013; F:troponin I binding; IPI:UniProtKB.
DR   GO; GO:0031014; F:troponin T binding; IPI:UniProtKB.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002086; P:diaphragm contraction; IEA:Ensembl.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   GO; GO:0043462; P:regulation of ATPase activity; ISS:BHF-UCL.
DR   GO; GO:0006937; P:regulation of muscle contraction; TAS:UniProtKB.
DR   GO; GO:0032972; P:regulation of muscle filament sliding speed; ISS:BHF-UCL.
DR   GO; GO:0010038; P:response to metal ion; IEA:Ensembl.
DR   GO; GO:0014883; P:transition between fast and slow fiber; IEA:Ensembl.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   Gene3D; 1.10.238.10; -; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 4.
DR   PROSITE; PS00018; EF_HAND_1; 3.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cardiomyopathy; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Metal-binding;
KW   Muscle protein; Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    161       Troponin C, slow skeletal and cardiac
FT                                muscles.
FT                                /FTId=PRO_0000073697.
FT   DOMAIN       16     51       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       52     87       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       92    127       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      128    161       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      65     76       1.
FT   CA_BIND     105    116       2.
FT   CA_BIND     141    152       3.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:3951483}.
FT   VARIANT       8      8       A -> V (in CMH13; increases calcium
FT                                sensitivity of the myofilaments).
FT                                {ECO:0000269|PubMed:18572189,
FT                                ECO:0000269|PubMed:19439414}.
FT                                /FTId=VAR_063070.
FT   VARIANT      29     29       L -> Q (in CMH13; impairs protein kinase
FT                                A dependent signaling from cardiac
FT                                troponin I to troponin C).
FT                                {ECO:0000269|PubMed:11385718,
FT                                ECO:0000269|PubMed:16302972}.
FT                                /FTId=VAR_019776.
FT   VARIANT      84     84       C -> Y (in CMH13; increases calcium
FT                                sensitivity of the myofilaments).
FT                                {ECO:0000269|PubMed:18572189,
FT                                ECO:0000269|PubMed:19439414}.
FT                                /FTId=VAR_063071.
FT   VARIANT     134    134       E -> D (in CMH13; no changes in calcium
FT                                sensitivity of the myofilaments).
FT                                {ECO:0000269|PubMed:18572189,
FT                                ECO:0000269|PubMed:19439414}.
FT                                /FTId=VAR_063072.
FT   VARIANT     145    145       D -> E (in CMH13; increases calcium
FT                                sensitivity of the myofilaments).
FT                                {ECO:0000269|PubMed:18572189,
FT                                ECO:0000269|PubMed:19439414}.
FT                                /FTId=VAR_063073.
FT   VARIANT     159    159       G -> R (in CMD1Z).
FT                                {ECO:0000269|PubMed:15542288}.
FT                                /FTId=VAR_043988.
FT   CONFLICT     96     96       Missing (in Ref. 4; AAB91994).
FT                                {ECO:0000305}.
FT   CONFLICT    115    115       D -> E (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         3      9       {ECO:0000244|PDB:3SD6}.
FT   HELIX        14     25       {ECO:0000244|PDB:3SD6}.
FT   TURN         30     32       {ECO:0000244|PDB:3SD6}.
FT   STRAND       35     37       {ECO:0000244|PDB:3SD6}.
FT   HELIX        38     47       {ECO:0000244|PDB:3SD6}.
FT   STRAND       51     53       {ECO:0000244|PDB:2JT8}.
FT   HELIX        54     64       {ECO:0000244|PDB:3SD6}.
FT   STRAND       66     68       {ECO:0000244|PDB:1J1D}.
FT   STRAND       71     73       {ECO:0000244|PDB:3SD6}.
FT   HELIX        74     85       {ECO:0000244|PDB:3SD6}.
FT   STRAND       90     92       {ECO:0000244|PDB:2JTZ}.
FT   HELIX        94    104       {ECO:0000244|PDB:1J1D}.
FT   STRAND      106    108       {ECO:0000244|PDB:2MLE}.
FT   STRAND      109    113       {ECO:0000244|PDB:1J1E}.
FT   HELIX       114    123       {ECO:0000244|PDB:1J1D}.
FT   STRAND      124    126       {ECO:0000244|PDB:1J1D}.
FT   HELIX       130    140       {ECO:0000244|PDB:1J1D}.
FT   STRAND      145    148       {ECO:0000244|PDB:1J1D}.
FT   HELIX       150    157       {ECO:0000244|PDB:1J1D}.
FT   TURN        158    160       {ECO:0000244|PDB:2JT0}.
SQ   SEQUENCE   161 AA;  18403 MW;  34DCCC46D503A312 CRC64;
     MDDIYKAAVE QLTEEQKNEF KAAFDIFVLG AEDGCISTKE LGKVMRMLGQ NPTPEELQEM
     IDEVDEDGSG TVDFDEFLVM MVRCMKDDSK GKSEEELSDL FRMFDKNADG YIDLDELKIM
     LQATGETITE DDIEELMKDG DKNNDGRIDY DEFLEFMKGV E
//
